- Home
- CSBR vs WHWK Comparison
CSBR vs WHWK Comparison
Compare CSBR & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CSBR | WHWK |
|---|---|---|
| Founded | 1985 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.0M | 95.2M |
| IPO Year | 1986 | N/A |
Fundamental Metrics
Financial Performance| Metric | CSBR | WHWK |
|---|---|---|
| Price | $7.10 | $2.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 18.5K | ★ 179.6K |
| Earning Date | 12-15-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $58,424,000.00 | $14,384,000.00 |
| Revenue This Year | $7.31 | N/A |
| Revenue Next Year | $12.01 | N/A |
| P/E Ratio | $38.57 | ★ N/A |
| Revenue Growth | ★ 9.06 | N/A |
| 52 Week Low | $5.59 | $1.39 |
| 52 Week High | $11.99 | $3.81 |
Technical Indicators
Market Signals| Indicator | CSBR | WHWK |
|---|---|---|
| Relative Strength Index (RSI) | 49.83 | 52.81 |
| Support Level | $6.22 | $2.24 |
| Resistance Level | $8.31 | $2.63 |
| Average True Range (ATR) | 0.42 | 0.16 |
| MACD | 0.10 | 0.00 |
| Stochastic Oscillator | 24.68 | 54.72 |
Price Performance
Historical ComparisonAbout CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About WHWK Whitehawk Therapeutics Inc.
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.